Objectives: To develop evidence-based EULAR recommendations for cardiovascular (CV)
risk management in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and …

Patients with rheumatoid arthritis (RA) and other inflammatory joint disorders (IJD) have
increased cardiovascular disease (CVD) risk compared with the general population. In 2009, the …

Objective Data regarding cardiovascular comorbidity and cardiovascular risk factors in
patients with psoriatic arthritis (PsA) are limited. To evaluate the cardiovascular risk profile, a …

Objectives: Patients with rheumatoid arthritis (RA) have an increased cardiovascular risk, but
the magnitude of this risk is not known precisely. A study was undertaken to investigate the …

Objective Rheumatoid arthritis (RA) is associated with an increased risk of cardiovascular
disease (CVD), but longitudinal observations are limited and the precise magnitude is …

Aims Preliminary evidence from animal and human studies shows that gut microbiota
composition and levels of microbiota-derived metabolites, including short-chain fatty acids (SCFAs)…

Objective To ascertain the prevalence of myocardial infarction (MI) in ankylosing spondylitis
(AS) relative to that in the general population. Methods A questionnaire was sent to 593 …

Background: Immunogenicity, specifically the onset of antibodies against tumour necrosis
factor (TNF) blocking agents, seems to play an important role in non-response to treatment …

Objective To study the usefulness of erythrocyte sedimentation rate (ESR), C‐reactive
protein (CRP), and serum amyloid A (SAA) for response prediction and monitoring of anti–tumor …

Objective. Preliminary evidence suggests that ankylosing spondylitis (AS) is associated with
an increased cardiovascular (CV) risk. We investigated subclinical atherosclerosis and …